[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 80, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2025, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 78, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2025, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 65, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2025, "totalPay": 607500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 57, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2025, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 70, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 71, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7934, "open": 0.84, "dayLow": 0.75, "dayHigh": 0.8431, "regularMarketPreviousClose": 0.7934, "regularMarketOpen": 0.84, "regularMarketDayLow": 0.75, "regularMarketDayHigh": 0.8431, "payoutRatio": 0.0, "beta": 1.524, "forwardPE": 0.27426523, "volume": 734305, "regularMarketVolume": 734305, "averageVolume": 859366, "averageVolume10days": 668140, "averageDailyVolume10Day": 668140, "bid": 0.588, "ask": 0.9751, "bidSize": 2, "askSize": 2, "marketCap": 17122444, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 2.97, "allTimeHigh": 937.5, "allTimeLow": 0.63, "fiftyDayAverage": 0.92314, "twoHundredDayAverage": 1.158605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23426190, "profitMargins": 0.0, "floatShares": 18809957, "sharesOutstanding": 22376427, "sharesShort": 2719644, "sharesShortPriorMonth": 3166818, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.12149999, "heldPercentInsiders": 0.023740001, "heldPercentInstitutions": 0.10795999, "shortRatio": 9.09, "shortPercentOfFloat": 0.1258, "impliedSharesOutstanding": 22376427, "bookValue": 3.739, "priceToBook": 0.20465365, "lastFiscalYearEnd": 1759190400, "nextFiscalYearEnd": 1790726400, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -37433912, "trailingEps": -3.38, "forwardEps": 2.79, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.608, "52WeekChange": -0.6789473, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 0.7652, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 4252290, "totalCashPerShare": 0.205, "ebitda": -38524176, "totalDebt": 1813273, "quickRatio": 0.095, "currentRatio": 0.622, "debtToEquity": 2.339, "returnOnAssets": -0.19450001, "returnOnEquity": -0.52418, "freeCashflow": -23379008, "operatingCashflow": -26552738, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Citius Pharmaceuticals, Inc.", "longName": "Citius Pharmaceuticals, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771029781, "regularMarketTime": 1771016401, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.55432, "regularMarketPrice": 0.7652, "fiftyDayAverageChange": -0.15793997, "fiftyDayAverageChangePercent": -0.17108995, "twoHundredDayAverageChange": -0.39340496, "twoHundredDayAverageChangePercent": -0.33955055, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": 3.0841587, "postMarketPrice": 0.7888, "postMarketChange": 0.023599982, "regularMarketChange": -0.0282, "regularMarketDayRange": "0.75 - 0.8431", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 859366, "fiftyTwoWeekLowChange": 0.13520002, "fiftyTwoWeekLowChangePercent": 0.21460322, "fiftyTwoWeekRange": "0.63 - 2.97", "fiftyTwoWeekHighChange": -2.2048001, "fiftyTwoWeekHighChangePercent": -0.74235696, "fiftyTwoWeekChangePercent": -67.89473, "dividendDate": 1496966400, "earningsTimestamp": 1770989400, "earningsTimestampStart": 1770989400, "earningsTimestampEnd": 1770989400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.38, "epsForward": 2.79, "epsCurrentYear": 1.66, "priceEpsCurrentYear": 0.46096388, "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]